首页> 美国卫生研究院文献>Microorganisms >Case Report of an Injectional Anthrax in France 2012
【2h】

Case Report of an Injectional Anthrax in France 2012

机译:法国注入炭疽病案例报告2012年

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(1) Background: is a spore-forming, Gram-positive bacterium causing anthrax, a zoonosis affecting mainly livestock. When occasionally infecting humans, provokes three different clinical forms: cutaneous, digestive and inhalational anthrax. More recently, an injectional anthrax form has been described in intravenous drug users. (2) Case presentation: We report here the clinical and microbiological features, as well as the strain phylogenetic analysis, of the only injectional anthrax case observed in France so far. A 27-year-old patient presented a massive dermohypodermatitis with an extensive edema of the right arm, and the development of drug-resistant shocks. After three weeks in an intensive care unit, the patient recovered, but the microbiological identification of was achieved after a long delay. (3) Conclusions: Anthrax diagnostic may be difficult clinically and microbiologically. The phylogenetic analysis of the strain PF1 confirmed its relatedness to the injectional anthrax European outbreak group-II.
机译:(1)背景:是一种孢子成形,革兰氏阳性细菌,导致炭疽病,一种影响主要牲畜的动物病。偶尔感染人类时,引起三种不同的临床形式:皮肤,消化和吸入炭疽。最近,已经在静脉注射药物中描述了注入炭疽形式。 (2)案例介绍:我们在此报告临床和微生物特征以及迄今为止在法国观察到的唯一注射炭疽病例的菌株系统。一位27岁的患者呈现出巨大的Dermohymatisitis,具有较大的水肿,右臂的水肿,以及耐药冲击的发展。在一个重症监护病房内三周后,患者恢复,但在长时间延迟后实现的微生物鉴定。 (3)结论:临床和微生物学可能困难的炭疽病诊断。菌株PF1的系统发育分析证实了其对注射炭疽欧洲爆发组-II的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号